PhD STUDENT - TRANSCRIPTIONAL DYNAMICS IN LEUKEMIA
Deadline for application
- MSc in Biology, Biomedicine, Bioinformatics or similar
- A high level of motivation and interest
- Excellent level of oral and written English
- Practical experience in molecular biology
- Bioinformatics skills (R, Bioconductor, etc.) will be positively evaluated
What we offer
- A 4-year funded PhD position starting in September/October 2020
- An exciting and innovative research project.
- Incorporation in a multinational and highly collaborative team.
- Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.
A funded PhD position is available in the recently-established Transcriptional Dynamics in Leukemia lab led by Dr Sergi Cuartero. Using a combination of genome-wide approaches, advanced microscopy imaging and single-cell technologies, the team investigates how mutations in epigenetic modifiers and transcription factors contribute to leukaemia development. We are located in the brand-new building of the Josep Carreras Leukaemia Research Institute (IJC), a top research institute in the Barcelona area and a highly stimulating scientific environment.
We are looking for a highly-motivated PhD student to investigate the molecular basis of acute megakaryoblastic leukaemia, a rare type of myeloid leukaemia. The project will elucidate how transcription factors and 3D genome organizers control normal megakaryocytic gene expression and how their mutations trigger leukaemia. The project will involve both experimental biology and bioinformatic analyses. Therefore, applicants will have a strong background in molecular biology and practical experience in either experimental biology (wet lab) or bioinformatics (dry lab). Excellent communication skills, creative thinking and fluent English are a prerequisite.
Please also visit our group webpage:
Who we are?
Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukaemia and other hematologic malignancies.
The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments. We aspire to understand the origin and development of leukaemia and other malignant haematological pathologies in order to be able to prevent them. We will work for a future in which all leukaemias will be curable.
The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.
The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.
This EC initiative aims to promote training, professional development, and mobility for all European scientists. The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists.
IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics.
Place of presentation of the candidacies
How to apply
To apply for this opportunity, please send your resume and a cover letter and (incl. the contact details of two referees) to email@example.com
Deadline for Applications
Please submit your application by July 12th, 2020.